![](/img/cover-not-exists.png)
O-0020 * OUTCOME ACCORDING TO TUMOR RAS MUTATION STATUS IN CRYSTAL STUDY PATIENTS WITH METASTATIC COLORECTAL CANCER RANDOMIZED TO FOLFIRI WITH OR WITHOUT CETUXIMAB AS FIRST-LINE TREATMENT
Van Cutsem, E., Lenz Heinz, J., Kohne, C. H., Heinemann, V., Tejpar, S., Melezinek, I., Beier, F., Duecker, K., van Krieken, H., Ciardiello, F.Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu193.20
Date:
June, 2014
File:
PDF, 32 KB
english, 2014